⌘K

Home/Filings/4/0001213900-25-050018

4//SEC Filing

Schuyler Kevin 4

Accession 0001213900-25-050018

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:01 PM ET

Size

5.5 KB

Accession

0001213900-25-050018

Insider Transaction Report

Form 4

Period: 2025-05-29

ADIAL PHARMACEUTICALS, INC.ADIL

Director

Transactions

Award
Stock Option (Right to Buy)
2025-05-29+28,000→ 28,000 total
Exercise: $0.69Exp: 2035-05-28→ Common Stock (28,000 underlying)

Footnotes (1)

[F1]The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718094

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 4:01 PM ET
Size: 5.5 KB

View on SEC.gov